Background illustration for clinical trials search

Paid Clinical Trials Louisiana

Discover 785 paid clinical trials in Louisiana. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer

for
Endometrial Cancer
Location: Miami Beach FL, Fort Lauderdale FL, Miami FL,
Sponsor: Daiichi Sankyo

Sex: Female

Age: 18+

Code: NCT07022483

Phase3, Recruiting

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

for
Type 2 Diabetes, Cortisol Excess
Location: Springfield MA, West Chester PA, Morehead City NC,
Sponsor: Sparrow Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07296484

Phase2, Recruiting

A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy

for
Gastrointestinal Neoplasms
Location: Boston MA, New Haven CT, Calgary, New Hyde Park NY,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT07218926

Phase3, Recruiting

Evaluation of PLG0206 in Prevention of Recurrent Infection in Patients Undergoing Debridement, Antibiotics, and Implant Retention (DAIR) for Treatment of a Periprosthetic Joint Infection (PJI) Following Knee Arthroplasty

for
Prosthetic-joint Infection
Location: Boston MA, Baltimore MD, Leland NC, Tamarac FL,
Sponsor: Peptilogics

Sex: All

Age: 18 - 70+

Code: NCT07214311

Phase2, Phase3, Recruiting

A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients

for
Hematopoietic and Lymphoid Cell Neoplasm,
Location: Philadelphia PA, Wilmington DE, Baltimore MD, Miami FL,
Sponsor: Children's Oncology Group

Sex: All

Age: 2 - 18

Code: NCT05711667

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

CanCan Body Composition Study

for
Healthy Participants, Young Healthy Adults,
Location: Baton Rouge LA
Sponsor: Pennington Biomedical Research Center

Sex: All

Age: 20 - 70+

Code: NCT07305753

Recruiting

A Study for Evaluating Safety & Efficacy of Topical Roflumilast 0.3% Foam in Hidradenitis Suppurativa

for
Hidradenitis Suppurativa
Location: New Orleans LA, Covington LA
Sponsor: Tulane University

Sex: All

Age: 18 - 70+

Code: NCT07077902

Phase2, Recruiting

A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH

for
Non-alcoholic Fatty Liver Disease
Location: New York NY, Jersey City NJ, Morehead City NC,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18 - 70+

Code: NCT07221188

Phase3, Recruiting

Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer

for
Head and Neck Squamous Cell Carcinoma,
Location: Richmond VA, Pittsburgh PA, Atlanta GA, Cincinnati OH,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06980038

Phase2, Recruiting

Effect of Physiologic Insulin Administration on Insulin Sensitivity and Cognition

for
Alzheimer s Disease, Alzheimer Blood Biomarkers,
Location: Baton Rouge LA
Sponsor: Pennington Biomedical Research Center

Sex: All

Age: 18+

Code: NCT07265323

Recruiting

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

for
Overweight, Obesity
Location: New Bedford MA, Hamden CT, Bridgeport CT,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07282600

Phase3, Recruiting

Cold and Compression Post TKA

for
Primary Osteoarthritis Patients Scheduled for Total Knee Replacement Surgery,
Location: New Orleans LA
Sponsor: Ochsner Health System

Sex: All

Age: 50+

Code: NCT07023185

Recruiting

A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors

for
SST2-positive Neuroendocrine Neoplasms, Neuroendocrine Tumors,
Location: New York NY, Philadelphia PA, Fairfax VA,
Sponsor: Crinetics Pharmaceuticals Inc.

Sex: All

Age: 18+

Code: NCT07129252

Phase1, Phase2, Recruiting

Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis

for
Myasthenia Gravis
Location: Farmington CT, New York NY, Raleigh NC, Boca Raton FL,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18 - 70+

Code: NCT07217587

Phase3, Recruiting

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

for
Endometrial Cancer, Recurrent or Progressive Endometrial Cancer
Location: Worcester MA, Hartford CT, Norwalk CT, Danbury CT,
Sponsor: Genmab

Sex: Female

Age: 18+

Code: NCT07166094

Phase3, Recruiting

Gait After THA: Direct Anterior vs Manual Posterior vs Robotic Posterior

for
Osteoarthritis (OA) of the Hip
Location: Metairie LA, New Orleans LA
Sponsor: Ochsner Health System

Sex: All

Age: 18+

Code: NCT07226973

Recruiting

A Safety, Tolerability, and Biomarker Trial of VS-041 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)

for
Heart, Heart Failure With Preserved Ejection Fraction (HFPEF)
Location: Brick NJ, Durham NC, North Miami Beach FL,
Sponsor: Vasa Therapeutics

Sex: All

Age: 50+

Code: NCT07219511

Phase1, Recruiting

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

for
Ovarian Neoplasms, Fallopian Tube Neoplasms,
Location: Scarborough ME, Providence RI, Farmington CT,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07213804

Phase3, Recruiting

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

for
Extensive-stage Small-cell Lung Cancer
Location: Burlington MA, White Plains NY, New York NY,
Sponsor: BioNTech SE

Sex: All

Age: 18+

Code: NCT06712355

Phase3, Recruiting

A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)

for
Cervical Cancer
Location: Halifax, Providence RI, Quebec, Sherbrooke, New York NY,
Sponsor: Merck Sharp & Dohme LLC

Sex: Female

Age: 18+

Code: NCT07216703

Phase3, Recruiting

Popular cities in Louisiana

Baton RougeNew OrleansShreveport